PerCP-Cy5.5 Mouse Anti-Human HLA-DR Antibody (S-R566)

產(chǎn)品型號：S0B5173

更新時間：2025-10-08

廠商性質(zhì)：生產(chǎn)廠家

訪問量：89

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

流式抗體封閉：如何有效避免實驗中的假陽性結(jié)果？

腸道黏蛋白 MUC2：從黏液屏障到疾病開關(guān)的雙重身份解碼

如何利用PD-1抗體在免疫學與腫瘤治療研究中取得突破？

抗獨特型抗體如何成為抗體藥物研發(fā)的關(guān)鍵工具？

產(chǎn)品介紹

HLA-DR is a subtype of the human leukocyte antigen （HLA） complex, specifically classified as a class II molecule, and is encoded by genes located on chromosome 6. It plays a crucial role in the immune system by presenting peptide antigens to CD4+ T cells, which subsequently trigger adaptive immune responses, including the activation of B cells and the production of antibodies. HLA-DR is primarily expressed on antigen-presenting cells such as macrophages, dendritic cells, and B cells, and its expression levels can indicate the degree of immune system activation. This molecule is also significant in clinical settings, as it is associated with various autoimmune diseases （e.g., rheumatoid arthritis linked to HLA-DR4） and is a key factor in determining the success of organ transplants. Additionally, HLA-DR has been studied in the context of cancer immunotherapy, where its expression on tumor cells can influence the effectiveness of immune-mediated tumor suppression.

上一個：S0B5164Alexa Fluor? 647 Rat Anti-Mouse CD21/CD35 antibody (S-R717)